ReviewFrontiers in immunology2026

GLP-1 receptor agonists in neurological diseases: mechanisms and therapeutic prospects from metabolism to neuroprotection.

Mengting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.